Richard Montes in

Richard Montes

Critic · DISC type C
Sr Director, CMC Statistics at Alnylam Pharmaceuticals
📍 Cambridge, Massachusetts, United States

Richard Montes is the Senior Director of CMC Statistics at Alnylam Pharmaceuticals, bringing over 25 years of experience in pharmaceutical drug development. A PhD graduate from Georgia Institute of Technology, his expertise spans RNAi, biosimilars, and biologics, with a focus on statistical strategies for process optimization and regulatory approval.

He played a key role in influencing the FDAs regulatory framework for demonstrating analytical similarity in biosimilars during his time at Hospira/Pfizer.

Read the full overview →
Experience
21 Years
Current Role
Sr Director, CMC Statistics
Job Level
Senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Richard shows up

Critic
Negotiator
ROI Driven

They don’t appreciate bells and whistles unless backed by data. They are quite likely to negotiate on pricing or other key terms. They choose to analyze logically and value facts to emotions.

Priorities

Topics Richard cares about

CMC Statistics
His core expertise for over 25 years, focusing on product life cycle, stability trending, and control strategies. He serves on conference committees related to this topic.
Drug Process Optimization
He has published case studies on using Design of Experiments (DOE) and Optimal Design to improve the efficiency and robustness of chemical processes in drug manufacturing.
+5 more topics Login to view topics
Career

Work history

3-2025
Sr Director, CMC Statistics
Alnylam Pharmaceuticals
5-2019 - 2-2025
Director, Statistics - CMC, TOQ
Alnylam Pharmaceuticals
5-2014 - 5-2019
Associate Director, Statistics - Biosimilars Pharmaceutical Sciences
Hospira, a Pfizer company
2-2012 - 4-2014
Manager Quality Statistics
Bristol-Myers Squibb
8-2007 - 2-2012
Sr. Research Statistician (CMC, Non-clinical)
Merck
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
PhD
Georgia Institute of Technology
Applied Statistics
Pennsylvania State University (online)
Social presence
in
Behavioral profile

DISC profile (public)

C

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals.

Juliette Jones
Juliette Jones
Head of Commercial Training & Development - International
Alnylam Pharmaceuticals
 Sharon Haynes Meakin, Ph.D.
Sharon Haynes Meakin, Ph.D.
Director, Head of Global Medical Affairs Training
Alnylam Pharmaceuticals
 Garrett Ingrando
Garrett Ingrando
Head of Marketing for North America
Alnylam Pharmaceuticals

More profiles

Discover additional public profiles from our index.

DW
David W.
Director Information Technology/CyberSecurity Architecture
Alnylam Pharmaceuticals
 Christopher Edlund
Christopher Edlund
Director, Technology Bioinformatics
Illumina
FD
Frank Diehl
Senior Vice President, Research and Development
Exact Sciences
 Carol Rothman
Carol Rothman
Educator for primary students
The Wesley School
Unlock the full playbookSee exactly how to sell to Richard. Free, 10 seconds.